Since CTCs with the CD45–EpCAM–CK7+N-cadherin– phenotype were significantly higher among CTCs in comparison with the primary tumor, it can be assumed that they have a pronounced capacity to intravasate and/or survive. This evidence concerns the gene PTPRC and neoplasm.